Featured Speakers

5th Annual Rare Disease Market Access & Commercialization Summit Top Reasons to Attend


  1. Gain payer insight into how to develop a compelling value proposition for bringing new products to market
  2. Learn how to develop an efficient, global expanded access program, including the transition to commercially-available product
  3. Receive guidance from C-Suite stakeholders from leading orphan drug manufacturers on innovative commercialization strategies
  4. Network with senior market access and commercialization professionals to collaborate on common challenges and forge mutually-beneficial partnerships
  5. Survey recent policy and industry-wide changes, such as the 21st Century Cures Act and overhaul previous practices

Biosimilars Market Access & Commercialization Summit Top Reasons to Attend


  1. Examine the first wave of approved and commercially-available biosimilars and establish best practices
  2. Assess regulatory, policy, and legal factors, such as the ruling on the 180-day rule and understand their effects on future biosimilars development
  3. Collaborate on roadblocks and challenges facing biosimilars and develop mitigation strategies
  4. Discuss how biosimilars can be used as an effective tool to reduce drug prices and serve as competition to reference products
  5. Strategize on how to better-educate external stakeholders, such as payers, patients, and providers on biosimilars

5th Annual Oncology Market Access & Commercialization Summit Top Reasons to Attend


  1. Review leading value models and the potential implications on reimbursement
  2. Overcome pricing and access hurdles with combination therapies and immuno-oncology
  3. Payer insights into market access best practices for reimbursement
  4. Provider and patient viewpoints to understand perspectives around value enhancing development, pricing, and distribution of therapies

Cell & Gene Therapy Commercialization Summit


  1. Insight into the evolving regulatory landscape and its impact on Cell & Gene Therapy market access
  2. Explore the payment models within the cell & gene therapy space
  3. Develop best practices in partnering with researchers to ensure successful cell & gene therapy from development to commercialization
  4. Understand how to move from clinical research to commercialization



Testimonials

Awesome, awesome, awesome! Fantastic speakers, thought provoking discussions and phenomenal content – by far the best conference I’ve been to in a long long time

–Director Digital Marketing Strategy, Digital Marketing Excellence & Innovation, Merck



Get Involved: